Navigation Links
Amylin Pharmaceuticals Reports First Quarter Financial Results
Date:4/18/2011

39$172,261  Revenues under collaborative agreements

1,8751,875Total revenues

152,714174,136Costs and expenses:  Cost of goods sold

12,54420,502  Selling, general and administrative

64,62573,313  Research and development

41,91545,261  Collaborative profit sharing

59,85167,900  Restructuring

2,858–Total costs and expenses

181,793206,976Operating loss

(29,079)(32,840)Interest and other income, net

(8,245)(5,363)Net loss

$ (37,324)$ (38,203)Net loss per share - basic and diluted

$
(0.26)$
(0.27)Shares used in computing net loss per share - basic and diluted

144,787142,702A reconciliation of reported GAAP operating loss to non-GAAP operating loss excluding non-cash and other items is provided in the table that follows (in thousands, unaudited):Quarter EndedMarch 31,20112010GAAP operating loss

$(29,079)$(32,840)Stock-based compensation

7,9179,703Other non-cash compensation

4,2387,088Depreciation and amortization

12,71214,153Amortization of deferred revenue

(1,875)(1,875)Restructuring

2,858–Non-GAAP operating loss

$ (3,229)$(3,771)AMYLIN PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)(unaudited)March 31,December 31,20112010AssetsCash, cash equivalents and short-term investments

$
460,158

$
442,663Restricted cash

15,000

15,000Accounts receivable, net

51,926

54,645Inventories, net

109,486

118,629Other current assets

31,923

45,458Property and equipment, net

811,295

811,745Other assets

42,103

43,289Total assets

$
,521,891

$
,531,429Liabilities and stockholders' equity Current liabilities

$
390,282

$
401,595Other liabilities, net of current portion

317,387

317,654Long-term debt

475,298

468,697Stockh
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
3. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
4. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
5. Amylin Pharmaceuticals Reports 2010 Financial Results
6. Amylin Pharmaceuticals to Webcast Year-End Financial Results
7. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
9. Amylin Pharmaceuticals Reports Third Quarter Financial Results
10. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
11. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Calif., April 24, 2012  A dose of 10 milligrams (mg) ... fermented soy germ-based nutritional supplement is as effective as a ... significantly and is even more effective for relieving muscle and ... women published in the June Journal of Women,s Health ...
... April 24, 2012  The Intellectual Property & Science ... to support R&D pharmaceutical leaders with a new ... use by AstraZeneca executives. The rich visualization dashboard ... , the company,s flagship life sciences platform, ...
Cached Medicine Technology:Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 2Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 3Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 4Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 5Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 6Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 7Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 8Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders 2
(Date:4/16/2014)... 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced ... of CDX-1401 in solid tumors, including long-term patient follow-up, ... (Vol 6 Issue 232). The data demonstrate robust antibody ... in patients with very advanced cancers and suggest that ...
(Date:4/16/2014)... , DOWNERS GROVE, Ill. April 16, 2014 ... of surveillance colonoscopy in average-risk patients with one to ... about 90 percent of cases. This may be an ... multicenter endoscopic database study to quantify adherence to guidelines ...
(Date:4/15/2014)... in the United States have nearly doubled since 1988, suggests ... Health, with obesity apparently to blame for the surge. The ... not hit all groups equally, with alarming increases in diabetes ... research reported in the April 15, 2014 issue of the ...
(Date:4/15/2014)... a decades-old medical mystery and in the process have found ... kill about 1.5 million people a year. The researchers say they ... that has been in use for more than 50 years ... it is to the microbes it attacks. , A report ...
(Date:4/15/2014)... California, San Diego School of Medicine have identified a mechanism ... liver disease and why the virus is able to persist ... pathogen, which infects an estimated 200 million people worldwide, attacks ... the cell,s innate ability to fight infection. It does this ...
Breaking Medicine News(10 mins):Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Breaking bad mitochondria 2
... China Healthcare Acquisition Corp. (the "Company") (NYSE Alternext ... meeting held today, March 5, 2009, its stockholders voted ... early distribution of the Company,s trust fund for the ... March 5, 2009. Today,s vote had the automatic effect ...
... FRANKLIN, Tenn., March 5 /PRNewswire/ -- ... services, today announced details for the release of its financial ... plans to issue its earnings release for the fourth quarter ... March 25, 2009, and will host a conference call on ...
... not getting services they need to prevent another attack, ... After suffering a stroke, the chances of having another ... aren,t getting the interventions they need to reduce that ... smoking cessation and exercise, and medical treatments, such as ...
... the Aspen Health Stewardship Project will unveil a new ... support of a roadmap for making smart, sustainable improvements ... which includes patient groups, and health employer and provider ... America by adopting a set of core principles to ...
... Re-enrollment OpportunitiesHARRISBURG, Pa., March 5 Insurance ... laid off from a job that offered health insurance ... provide them with relief on premiums and that now ... information."I want to let Pennsylvanians know that additional help ...
... it has received a $76 million grant from the Bill ... and young child nutrition in developing countries in Africa and ... to increase rates of exclusive breastfeeding and improve complementary feeding ... children die and millions more are permanently disabled as a ...
Cached Medicine News:Health News:China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date 2Health News:Second Stroke Prevention Efforts Found Wanting 2Health News:Second Stroke Prevention Efforts Found Wanting 3Health News:Aspen Institute to Introduce Roadmap for Responsible Health Care Reform, New Coalition To Call For Sustainable Improvements 2Health News:Pennsylvanians Encouraged to Take Another Look at COBRA Options 2Health News:AED Receives Gates Foundation Grant to Improve Nutrition and Reduce Deaths Among Young Children in Developing Countries 2
...
...
... biomechanical properties influence the results and ... and may hold clues to diagnosing ... assessing the biomechanical properties of corneal ... practitioners and researchers to measuring purely ...
The Surgiflex WAVE is a comfortable, easy to use, versatile, and interchangeable suction-irrigation device....
Medicine Products: